Triple-negative breast cancer: treatment challenges and solutions

Triple-negative breast cancers (TNBCs) are defined by the absence of estrogen and progesterone receptors and the absence of HER2 overexpression. These cancers represent a heterogeneous breast cancer subtype with a poor prognosis. Few systemic treatment options exist besides the use of chemotherapy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Collignon, Joëlle, Lousberg, Laurence, Schroeder, Hélène, Jerusalem, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881925/
https://www.ncbi.nlm.nih.gov/pubmed/27284266
http://dx.doi.org/10.2147/BCTT.S69488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881925/
https://www.ncbi.nlm.nih.gov/pubmed/27284266
http://dx.doi.org/10.2147/BCTT.S69488

Ejemplares similares